Market Overview

420 Investor's Alan Brochstein, On Recent Bull Run In Cannabis Stocks, Tells Benzinga Tilray, Cronos & Canopy Growth Benefit Disproportionately From U.S. Listing Status, Adds Those Cos. 'Seem expensive to me. Tilray, especially, with its very tight float'


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for TLRY

Oct 2018BenchmarkInitiates Coverage OnBuy
Oct 2018Cowen & Co.MaintainsOutperformOutperform
Sep 2018Northland SecuritiesDowngradesOutperformMarket Perform

View More Analyst Ratings for TLRY
View the Latest Analyst Ratings

Posted-In: Analyst Color Cannabis Exclusives Markets Analyst Ratings Trading Ideas


Related Articles (CGC + CRON)

Wedbush Turns Bearish On Chipotle, Says Risks Are Underappreciated

AbbVie's Rare Blood Cancer Drug Combo Snags FDA Approval